NEXENTIS TECHNOLOGIES INC. Investments, Fair Value Disclosure
NEXENTIS TECHNOLOGIES INC. (NXTS) had Investments, Fair Value Disclosure of $1.25 million as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Notes › Fair Value Disclosures
us-gaap:InvestmentsFairValueDisclosure · last filed 2023-11-14
- 2023-09-30: Investments, Fair Value Disclosure $1.25M.
- 2023-06-30: Investments, Fair Value Disclosure $903.37K.
| Period end | Investments, Fair Value Disclosure |
|---|---|
| 2023-09-30 | $1.25M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $903.37K 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |